Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing

Y Hua, Y Zheng, Y Yao, R Jia, S Ge… - Journal of Translational …, 2023 - Springer
Metformin is a well-known anti-diabetic drug that has been repurposed for several emerging
applications, including as an anti-cancer agent. It boasts the distinct advantages of an …

The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances

P Saraei, I Asadi, MA Kakar… - Cancer management and …, 2019 - Taylor & Francis
Metformin is a widely used drug in today's prescriptions by physicians due to its specific
effects in treating and curing type II diabetes. Diabetes is a common disease that may occur …

Betulin and betulinic acid: Triterpenoids derivatives with a powerful biological potential

A Hordyjewska, A Ostapiuk, A Horecka… - Phytochemistry …, 2019 - Springer
Betulin, a pentacyclic triterpene and a plant pentacyclic triterpene metabolite, can be found
in large quantities in the outer bark of the birches (Betula, Betulaceae). Betulinic acid …

Analysis of clonogenic growth in vitro

N Brix, D Samaga, C Belka, H Zitzelsberger… - Nature protocols, 2021 - nature.com
The clonogenic assay measures the capacity of single cells to form colonies in vitro. It is
widely used to identify and quantify self-renewing mammalian cells derived from in vitro …

Diabetes and cancer: a consensus report

E Giovannucci, DM Harlan, MC Archer… - CA: a cancer journal …, 2010 - Wiley Online Library
Epidemiologic evidence suggests that cancer incidence is associated with diabetes as well
as certain diabetes risk factors and treatments. This consensus statement of experts …

Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways

Y Wang, W Xu, Z Yan, W Zhao, J Mi, J Li… - Journal of Experimental & …, 2018 - Springer
Background Metformin is a commonly used drug for the treatment of diabetes. Accumulating
evidence suggests that it exerts anti-tumor effects in many cancers, including multiple …

Obesity and cancer

KY Wolin, K Carson, GA Colditz - The oncologist, 2010 - academic.oup.com
Weight, weight gain, and obesity account for approximately 20% of all cancer cases.
Evidence on the relation of each to cancer is summarized, including esophageal, thyroid …

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis

A DeCensi, M Puntoni, P Goodwin, M Cazzaniga… - Cancer prevention …, 2010 - AACR
Metformin, an insulin-lowering agent, has been associated with decreased cancer risk in
epidemiologic studies in diabetic patients. We performed a comprehensive literature search …

Diabetes and cancer

P Vigneri, F Frasca, L Sciacca… - Endocrine-related …, 2009 - erc.bioscientifica.com
Diabetes and cancer are two heterogeneous, multifactorial, severe, and chronic diseases.
Because of their frequency, reciprocal influences–even minor influences–may have a major …

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

HA Hirsch, D Iliopoulos, PN Tsichlis, K Struhl - Cancer research, 2009 - AACR
The cancer stem cell hypothesis suggests that, unlike most cancer cells within a tumor,
cancer stem cells resist chemotherapeutic drugs and can regenerate the various cell types …